Is a complete MLEC research report available?

No complete published report is available for Moolec Science SA (MLEC) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Moolec Science SA (MLEC)

NASDAQ: MLEC · USD

$7.20

-0.02 (-0.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first MLEC analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	15M
Shares out	2.1M
Volume	3,438.843
Beta	-0.32

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Market cap: 15M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All MLEC indicators

Market & fundamental data

Available fields

139

Groups with data

Currency

USD

Showing 139 of 139 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001937737
Company name	Moolec Science SA
Country	Cayman Islands
Country code	US
Cusip	G6223S125
Employees Change	7%
Employees Change Percent	15.56
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	KYG6223S1259
Last refreshed	2026-07-31
Market cap	$15M
Market cap category	Nano-Cap
Price	$7.2
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2000
Symbol	MLEC
Website	https://www.moolecscience.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
FCF yield	-40.72%
PS Forward	3.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-24.44%
EBITDA Margin	-17.53%
Net Income Growth Years	0%
ROIC	-28.64

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-84.9%
Cagr3y	-75.51%
EPS Growth Years	0
Revenue Growth	170.36x
Revenue Growth Q	948.32x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Current Assets	$9.5M
Current Liabilities	$6.5M
WACC	2.49

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.44%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-84.88%
200-day SMA	7.86
3Y total return	-98.53%
50-day SMA	7.48
50-day SMA vs 200-day SMA	50under200
All Time High	3,330
All Time High Change	-99.78%
All Time High Date	2023-01-06
All Time Low	3.08
All Time Low Change	134.07%
All Time Low Date	2025-12-23
ATR	0.71
Beta	-0.32
Beta1y	0.55
Beta2y	0.44
Ch YTD	88.53
High	7.2
High52	53.4
High52 Date	2025-07-31
High52ch	-86.52%
Low	7.1
Low52	3.08
Low52 Date	2025-12-23
Low52ch	134.07%
Ma50ch	-3.76%
Price vs 200-day SMA	-8.37%
RSI	47.17
RSI Monthly	22.64
RSI Weekly	39.42
Sharpe ratio	-0.12x
Sortino ratio	-0.2
Total Return	-1.44%
Tr YTD	88.53
Tr1m	-11%
Tr1w	0.28%
Tr3m	-19.91%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	573,192%
Float Percent	27.55%
Net Borrowing	4,786,952
Shares Insiders	0.45%
Shares Institutions	0.8%
Shares Out	2,080,304
Short Float	1.64%
Short Ratio	0.84
Short Shares	0.45

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-7M
Adjusted OCF	-6,563,702
Average Volume	12,249.85x
CAPEX	$-402,063
Ch1m	-11
Ch1w	0.28
Ch1y	-84.88
Ch3m	-19.91
Ch3y	-98.53
Ch6m	11.28
Change	-0.28%
Change From Open	0.28
Close	7.22
Days Gap	-0.55
Depreciation Amortization	1,069,251
Dollar Volume	24,759.7
Earnings Date	2026-08-11
Earnings Time	bmo
EBIT	$-82.8M
EBITDA	$-59.4M
F Score	0
FCF	$-6.1M
FCF Per Share	$-2.93
Financing CF	5,946,485
Fiscal Year End	June
Founded	2,008
Goodwill	281,034
Investing CF	-270,171
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2025-12-29
Last Report Date	2024-12-31
Last Split Date	2026-01-05
Last Split Type	Reverse
Last10k Filing Date	2025-12-29
Ma150	7.78
Ma150ch	-7.47%
Ma20	7.36
Ma20ch	-2.17%
Net CF	228,428
Next Earnings Date	2026-08-11
Open	7.18
Optionable	No
Position In Range	100
Post Close	7.2
Postmarket Change Percent	-2.92
Postmarket Price	$6.99
Ppne	1,632,314
Price Date	2026-07-30
Relative Volume	0.28x
SBC By Revenue	11.06x
Share Based Comp	866,661
Tr6m	11.28%
Volume	3,438.8

Moolec Science SA (MLEC)

Coverage state: Market snapshot only — no published research

Generate the first MLEC analysis

Price

Financial snapshot

Fair-value bridge

Latest news · MLEC

Valuation

Profitability

Trading

Next earnings

Sector percentile context

All MLEC indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on MLEC

Frequently asked questions